[HTML][HTML] Artificial intelligence in bone marrow histological diagnostics: potential applications and challenges

L van Eekelen, G Litjens, KM Hebeda - Pathobiology, 2024‏ - karger.com
The expanding digitalization of routine diagnostic histological slides holds a potential to
apply artificial intelligence (AI) to pathology, including bone marrow (BM) histology. In this …

Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient

WJ Wong, O Pozdnyakova - International Journal of Laboratory …, 2019‏ - Wiley Online Library
Elevated peripheral blood (PB) cell counts, such as leukocytosis, thrombocytosis, and
polycythemia, are often the presenting symptom in patients with myeloproliferative …

Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms

M Vukotić, S Kapor, T Dragojević, D Đikić… - … & Molecular Medicine, 2022‏ - nature.com
Although bone marrow-derived mesenchymal stromal cells (BM-MSCs) have been identified
as a major cellular source of fibrosis, the exact molecular mechanism and signaling …

Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms

L Boiocchi, RP Hasserjian, O Pozdnyakova, WJ Wong… - Human pathology, 2019‏ - Elsevier
The introduction of next-generation sequencing has broadened the genetic landscape of
myeloproliferative neoplasms (MPNs) beyond JAK2, MPL, and CALR. However, the …

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory …

WJ Wong, M Baltay, A Getz, K Fuhrman, JC Aster… - PLoS …, 2019‏ - journals.plos.org
The Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) share similar
molecular characteristics in that they frequently harbor hotspot mutations in JAK2, CALR or …

The temporal sequence and the differences in somatic mutation acquisition determines clinical behaviors of JAK2-positive myeloproliferative neoplasms

JM Byun, S Song, Y Koh, SS Yoon, D Kim - Anticancer research, 2019‏ - ar.iiarjournals.org
Background/Aim: We have yet to understand why JAK2-positive myeloproliferative
neoplasms (MPN) patients manifest different phenotypes despite harboring JAK2 mutations …

The Imperative of Implementing Precision Medicine in the Context of Diabetes and Treatment

G Ghajari, Y Bermas, M Saremi - Personalized Medicine Journal, 2023‏ - pmjournal.ir
Precision medicine is a medical approach that involves customizing therapy for an individual
by using extensive biological and external data. The rapid progress in the disciplines of …

Philadelphia-negative myeloproliferative neoplasms: laboratory workup in the era of next-generation sequencing

Z Zuo, S Li, J Xu, MJ You, JD Khoury… - Current hematologic …, 2019‏ - Springer
Abstract Purpose of Review To review the impact of next-generation sequencing (NGS) on
laboratory approach of myeloproliferative neoplasms (MPNs). Recent Findings Next …

Designing and Simulating the Structure of an Effective Immunotoxin in Breast Cancer

M Maleknejadyazdi… - Personalized Medicine …, 2023‏ - pmjournal.ir
Immunotoxins have been used for cancer treatment. The immunotoxin binds to the surface
antigen on the cancer cell, enters inside the cell by endocytosis1, and destroys the cancer …

[HTML][HTML] Calreticulin gene mutation in BCR-ABL1 negative myeloproliferative neoplasms: relation to clinical, laboratory and morphological findings

OM Hendy, HM El Gendi, NA Safwat… - The Egyptian Journal …, 2024‏ - journals.lww.com
Background Essential thrombocytosis is an indolent myeloproliferative neoplasm (MPN) that
may be complicated by vascular events. This disorder may also transform into more …